MONDAY, March 31, 2025 (HealthDay News) -- Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased dramatically among people with type 1 diabetes, raising safety concerns among experts, a new study says
2:e1054549
However, it is difficult to segregate these presentations in the pediatric age group
Improved overall health markers: Many patients experience lower blood pressure and better cholesterol profiles
For more information on our services and to explore other wellness solutions, feel free to explore our website or contact us and discover how Elive Health can support your journey towards a healthier, more balanced life
Pros: What Ozempic (Semaglutide) actually does well Significant, sustained weight loss - proven in gold-standard trials: The 2021 landmark STEP-1 clinical trial in New England Journal of Medicine tested once-weekly semaglutide 2.4 mg in adults with overweight or obesity